Optimizing Treatment Strategies for Tardive Dyskinesia
Tardive dyskinesia (TD), a side effect of neuroleptic medications, involves involuntary movements and carries challenges in management. With FDA-approved treatments like Ingrezza and Austedo showing promise, optimizing TD care becomes pivotal. Integrating preventative measures and understanding drug interactions form the basis for an effective treatment strategy, enhancing quality of life for those affected by TD. […]
3 minute read